Medical Net,Inc. (JP:3645)
:3645
Top Page
Medical Net,Inc.
(3645)
Select Model
Select Model
Rating:45Neutral
Price Target:
¥289.00
▼(-3.02% Downside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by weak financial performance, marked by a return to net losses and a sharp deterioration to negative operating and free cash flow, despite strong revenue growth. Technicals add modest downside bias with the stock trading below key moving averages and negative MACD. Valuation is a relative positive with a low P/E and modest dividend yield, but it is not enough to offset the recent profitability and cash-flow weakness.
Positive Factors
Revenue Growth
A near-doubling of revenue in 2025 indicates strong top-line momentum and market demand for the company's platforms. Sustained revenue growth creates optionality to invest in product, marketing and partnerships and can provide long-term scale benefits if margins are stabilized.
Negative Factors
Profitability Deterioration
Margins have eroded materially and the business moved to a net loss in 2025. Sustained margin compression undermines the economics of the model, reduces reinvestment capacity, and makes it harder to fund growth organically without reversing cost trends or improving pricing power.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A near-doubling of revenue in 2025 indicates strong top-line momentum and market demand for the company's platforms. Sustained revenue growth creates optionality to invest in product, marketing and partnerships and can provide long-term scale benefits if margins are stabilized.
Read all positive factors
Medical Net,Inc. (3645) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.69B
Dividend Yield1.01%
Average Volume (3M)13.39K
Price to Earnings (P/E)10.1
Beta (1Y)0.58
Revenue Growth13.89%
EPS Growth82.37%
CountryJP
Employees289
SectorCommunication Services
Sector Strength97
IndustryInternet Content & Information
Share Statistics
EPS (TTM)7.52
Shares Outstanding10,773,000
10 Day Avg. Volume10,010
30 Day Avg. Volume13,390
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.65
Price to Sales (P/S)0.47
P/FCF Ratio-13.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medical Net,Inc. Business Overview & Revenue Model
Company Description
Medical Net, Inc. provides medical and life related information services through Internet. It operates dental implant treatment, orthodontic and aesthetic dental treatment, and dental comprehensive information sites; and offers dental clinic manag...
How the Company Makes Money
null...
Medical Net,Inc. Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
52
Neutral
Cash Flow
30
Negative
| Breakdown | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.07B | 5.25B | 4.50B | 3.75B | 2.90B |
| Gross Profit | 1.96B | 1.84B | 1.78B | 1.46B | 1.18B |
| EBITDA | 170.87M | 351.75M | 442.45M | 479.57M | 356.13M |
| Net Income | -68.15M | 5.96M | 116.18M | 380.10M | 129.67M |
Balance Sheet | |||||
| Total Assets | 4.08B | 3.99B | 3.47B | 3.15B | 2.11B |
| Cash, Cash Equivalents and Short-Term Investments | 1.46B | 1.53B | 1.52B | 1.13B | 868.66M |
| Total Debt | 1.26B | 1.03B | 790.83M | 773.54M | 383.31M |
| Total Liabilities | 2.31B | 2.06B | 1.54B | 1.42B | 846.98M |
| Stockholders Equity | 1.72B | 1.91B | 1.92B | 1.70B | 1.24B |
Cash Flow | |||||
| Free Cash Flow | -212.40M | 86.79M | 408.50M | 340.39M | 378.84M |
| Operating Cash Flow | -80.86M | 119.59M | 429.13M | 342.55M | 391.87M |
| Investing Cash Flow | -259.73M | -285.40M | -62.37M | -355.05M | -87.99M |
| Financing Cash Flow | 219.18M | 144.11M | -17.90M | 282.17M | -34.03M |
Medical Net,Inc. Technical Analysis
Positive
298.00
Price Trends
300.64
Positive
300.48
Positive
305.20
Negative
Market Momentum
0.75
Negative
57.95
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3645, the sentiment is Positive. The current price of 298 is below the 20-day moving average (MA) of 298.70, below the 50-day MA of 300.64, and below the 200-day MA of 305.20, indicating a neutral trend. The MACD of 0.75 indicates Negative momentum. The RSI at 57.95 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3645.
Medical Net,Inc. Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥302.41B | 21.83 | ― | ― | 23.28% | 26.56% | |
63 Neutral | ¥49.37B | 58.36 | ― | ― | 22.37% | 655.34% | |
61 Neutral | ¥20.29B | 26.23 | ― | ― | 28.90% | 29.06% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
55 Neutral | ¥6.88B | 27.11 | ― | ― | 42.83% | 26.89% | |
52 Neutral | ¥5.10B | -13.71 | ― | 0.77% | 4.75% | ― | |
45 Neutral | ¥2.69B | 10.09 | ― | 1.01% | 13.89% | 82.37% |
* Communication Services Sector Average
JP:3645
Medical Net,Inc.
305.00
18.64
6.51%
JP:2454
All About, Inc.
368.00
52.48
16.63%
JP:4176
coconala Inc.
286.00
42.00
17.21%
JP:4194
Visional, Inc.
7,519.00
389.00
5.46%
JP:5139
OpenWork Inc.
955.00
218.00
29.58%
JP:5243
note inc.
2,695.00
1,095.00
68.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.